The Trump administration’s cuts to climate research and weather forecasting are “blinding” the U.S. to oncoming threats to ...

The FDA has launched a review of clinical trials involving the export of US patients’ living cells to China and other ...

From AI-powered inspections to bold regulatory shifts on dyes and sugar, the FDA has made waves in 2025. Here are the 17 most ...

The FDA has launched a review of clinical trials that plan to send American citizens' living cells to 'hostile' countries – ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

US FDA halts new clinical trials that export Americans’ cells to foreign labs in hostile countries for genetic engineering: Maryland Friday, June 20, 2025, 09:00 Hrs [IST] The U ...

The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ ...

Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...

Hackers infiltrated one grocery distributor, and within days, there were bare shelves at stores around the country and even some pharmacies unable to fill prescriptions. That’s not the beginning of ...

Explore how food sensors are enhancing safety and transparency across the supply chain—and why regulatory approvals are ...

The order comes as the Trump administration vows to bring transparency back to the United States' health industry.

Under the new initiative, companies may receive a voucher enabling FDA review to be shortened from the standard 10–12 months to just 1–2 months following final application submission if the drug ...